The Global Point of Care Testing Market size was estimated at USD 39.1 billion in 2023 and is projected to reach USD 78.48 billion in 2030 at a CAGR of 9.1% during the forecast period 2023-2030.
Point-of-care testing, often abbreviated as POCT, is a term that refers to medical diagnostic testing conducted in close proximity to the patient. This type of testing is designed to facilitate immediate medical decisions based on the results and ongoing monitoring of the patient's condition. Also known as with-patient testing, POCT is a critical tool in the medical field. It enables healthcare professionals, such as doctors, to obtain accurate, lab-quality diagnostic results in a matter of minutes, as opposed to waiting for hours or even days for results from a traditional laboratory. The primary advantage of point-of-care testing is its ability to expedite patient care. By providing real-time results, it ensures that patients receive the most effective and efficient care possible, right when they need it. This is particularly beneficial in emergency situations or in remote locations where access to a full-scale laboratory may be limited.